Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Butylphthalide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116253705A reveals a novel iron-catalyzed route for n-butylphthalide. This method offers mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Advanced synthesis of high-purity butylphthalide via safe aqueous reduction and vacuum distillation. Ideal for reliable pharma intermediate supply chains.
Patent CN114032258B reveals enzymatic route for L-butylphthalide intermediate. Offers high purity and cost efficiency for pharmaceutical supply chains.
Patent CN113200948A reveals a cost-effective copper-catalyzed route for chiral phthalides, offering high enantioselectivity and supply chain advantages for pharmaceutical manufacturers.
Novel THF-based Grignard route ensures scalable production of anti-ischemia drug intermediates. Eliminates column chromatography for cost-effective supply chain solutions and high purity standards.
Advanced Raney Nickel catalyzed synthesis of butylphthalide eliminates high-energy rectification. Delivers >99% purity for reliable API intermediate supply chains.
Novel patent CN108623456A offers mild conditions for butylphthalide. Reduces cost and improves safety for reliable pharmaceutical intermediate supplier.
Novel Raney Nickel catalytic method reduces energy and solvent costs for pharmaceutical intermediate manufacturing supply chain efficiency and high purity output.
Patent CN108623456A introduces a mild synthesis route eliminating high-temperature reactions and Grignard reagents to enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.